Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-30

FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc. The approval updates the labeling for this ADHD t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intuniv (guanfacine hydrochloride)

Snippet

SUPPL AP for INTUNIV (GUANFACINE)